Home Delphia Therapeutics

Delphia Therapeutics

In operation
Series A
Developer of Novel Cancer Drugs
Basic
Enterprise Profile

Basic Information

Delphia Therapeutics is a startup that, unlike most drugs which treat cancer by inhibiting targets, aims to develop novel cancer drugs based on the strategy of activating key signaling pathways.
Delphia Therapeutics, Inc
Cambridge,Massachusetts,United States of America
unclear
January 01, 2022
contact@delphiatx.com

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Technology
Targeted Technology
Concept
Therapeutic Products Colorectal Cancer
Application Scenarios
Innovative Drugs